Related to Merck & Co. Teams Up with India’s Serum Institute to Develop PCV Vaccine for Developing World

• Merck & Co. Axes Alzheimer Deal with Acumen, Nabs Exelixis’ PI3K-Delta Program
  
• Merck & Co, Supera Farma Set Up Brazilian JV
  
• Merck & Co. Raises Its Bet on Emerging Markets
  
• Merck & Co. Signs Up Abbott to Develop a Companion Diagnostic for Anticancer Candidate
  
• Codexis, Merck & Co. Develop Prototype Enzyme-Based Method for Producing Boceprevir
  
• VC Firm Flagship Ventures Joins a Merck Fund in Launching Biotech Startups
  
• Merck & Co. Pays Endocyte $120M for Phase III Folate Receptor-Targeting Anticancer Drug
  
• Merck & Co. Partners with Trevena to Identify Biased GPCR Receptor Ligands
  
• Merck & Co. to Evaluate Transdermal Vaccine Delivery System
  
• Nuron Biotech Acquires Another Vaccine
  
• Pfenex Division Begins Product Capacity Expansion
  
• Electronics Giant Samsung Makes First Big Biotech Play
  
• Merck Joins Pfizer to Develop Type 2 Diabetes Drug
  
• Merck Launches Up To $430M Diabetes Collaboration with Abide
  
• Merck & Co. Gains Rights to Santen's Glaucoma Drug in the Americas, W. Europe, and Africa
  
• Wellcome Trust and Merck Set Up JV to Focus on Vaccines for Developing Nations
  
• Merck Teams with Adcock Ingram to Market OTC and Rx Products in South Africa
  
• Merck & Co., MVI, and NYU Langone Medical Center Partner to Develop Malaria Vaccine
  
• Intercell and Merck Terminate Phase II/III S. aureus Preventive Vaccine Trial
  
• Merck & Co. Licenses Protein Sciences’ Insect Cell Vaccine Production Platform